柳药集团 - Financials

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
+Revenue	21.2B	20.8B	19.1B	17.1B	15.7B
Revenue Growth %	1.8%	9.2%	11.2%	9.4%	--
Total Revenue	21.2B	20.8B	19.1B	17.1B	15.7B
Cost Of Revenue	18.8B	18.3B	16.9B	15.2B	13.7B
+Gross Profit	2.4B	2.5B	2.2B	2.0B	1.9B
Gross Margin %	11.4%	11.9%	11.5%	11.4%	12.4%
Total Operating Cost	20.2B	19.8B	18.2B	16.4B	14.8B
Selling Expenses	630.0M	554.0M	534.0M	490.0M	426.0M
Admin Expenses	424.0M	470.0M	417.0M	412.0M	394.0M
Rd Expenses	39.6M	36.6M	25.8M	18.6M	8.7M
Finance Expenses	235.0M	249.0M	220.0M	204.0M	183.0M
+Operating Income	1.0B	1.0B	890.0M	753.0M	905.0M
Operating Margin %	4.7%	5.0%	4.7%	4.4%	5.8%
Non Operating Income	14.6M	3.5M	3.9M	6.1M	23.3M
Non Operating Expenses	15.0M	3.8M	3.6M	4.5M	10.4M
Investment Income	-95,300	-706,200	7.4M	2.0M	4.6M
Asset Disposal Income	3.0M	1.1M	-1,100	86,400	11.8M
Asset Impairment Loss	--	--	--	--	--
Other Income	17.1M	13.5M	7.3M	12.7M	13.2M
Income Before Tax	1.0B	1.0B	890.0M	755.0M	918.0M
Income Tax	136.0M	137.0M	131.0M	114.0M	136.0M
+Net Income	868.0M	907.0M	759.0M	641.0M	782.0M
Net Margin %	4.1%	4.4%	4.0%	3.7%	5.0%
Net Income Attributable	855.0M	850.0M	702.0M	564.0M	712.0M
Minority Interest	12.7M	57.0M	57.5M	77.3M	70.1M
Eps Basic	2.21	2.35	1.94	1.56	1.96
Eps Diluted	2.21	2.35	1.56	1.56	1.96

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
Cash And Equivalents	3.7B	3.1B	3.9B	3.4B	3.5B
Accounts Receivable	10.6B	10.4B	8.7B	7.3B	6.4B
Notes Receivable	177.0M	210.0M	216.0M	187.0M	219.0M
Notes And Accounts Receivable	10.8B	10.7B	8.9B	7.5B	6.6B
Prepayments	334.0M	408.0M	455.0M	279.0M	239.0M
Inventory	2.6B	2.3B	2.5B	1.8B	1.6B
Total Current Assets	18.6B	17.3B	16.1B	13.4B	12.8B
Long Term Equity Investment	3.6M	5.4M	1.1M	--	--
Fixed Assets	--	1.0B	963.0M	818.0M	674.0M
Fixed Assets Total	1.0B	1.0B	963.0M	818.0M	674.0M
Construction In Progress	--	36.3M	14.0M	115.0M	117.0M
Construction In Progress Total	83.1M	36.3M	14.0M	115.0M	117.0M
Intangible Assets	223.0M	240.0M	257.0M	227.0M	208.0M
Long Term Deferred Expenses	55.7M	64.8M	71.5M	91.5M	96.0M
Total Non Current Assets	2.7B	2.8B	2.5B	2.5B	2.0B
Total Assets	21.3B	20.2B	18.6B	15.9B	14.8B
Short Term Borrowings	2.9B	3.2B	3.0B	2.7B	2.8B
Accounts Payable	3.7B	3.6B	3.6B	2.9B	2.8B
Advance Receipts	--	--	--	--	--
Contract Liabilities	71.2M	34.8M	103.0M	50.6M	23.7M
Total Current Liabilities	11.9B	11.6B	10.8B	8.6B	8.2B
Long Term Borrowings	214.0M	229.0M	238.0M	246.0M	198.0M
Total Non Current Liabilities	1.5B	1.5B	1.4B	1.4B	1.2B
Total Liabilities	13.3B	13.1B	12.2B	10.1B	9.4B
Paid In Capital	399.0M	362.0M	362.0M	362.0M	363.0M
Capital Reserve	2.3B	2.0B	2.0B	2.0B	2.0B
Surplus Reserve	267.0M	267.0M	267.0M	267.0M	267.0M
Retained Earnings	4.5B	3.9B	3.2B	2.7B	2.4B
Minority Equity	313.0M	446.0M	396.0M	346.0M	346.0M
Equity Attributable	7.6B	6.6B	6.0B	5.5B	5.1B
Total Equity	7.9B	7.1B	6.4B	5.8B	5.4B

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
Cash From Sales	25.0B	22.4B	21.2B	18.5B	17.3B
Tax Refunds Received	--	2.7M	9.1M	--	3.5M
Total Operating Cash Inflow	25.3B	22.7B	21.5B	18.9B	17.9B
Cash Paid For Goods	22.6B	20.4B	19.4B	17.1B	15.7B
Cash Paid To Employees	531.0M	519.0M	441.0M	424.0M	356.0M
Taxes Paid	575.0M	535.0M	530.0M	430.0M	489.0M
Total Operating Cash Outflow	24.5B	22.1B	21.0B	18.6B	17.2B
Operating Cash Flow	839.0M	594.0M	506.0M	333.0M	665.0M
Total Investing Cash Inflow	1.3B	309.0M	617.0M	276.0M	673.0M
Total Investing Cash Outflow	1.5B	511.0M	1.0B	569.0M	918.0M
Investing Cash Flow	-142.0M	-202.0M	-383.0M	-293.0M	-244.0M
Cash From Borrowings	4.2B	4.2B	4.7B	3.6B	4.4B
Dividends And Interest Paid	414.0M	361.0M	379.0M	386.0M	347.0M
Debt Repayments	4.3B	4.1B	4.4B	3.3B	2.9B
Total Financing Cash Inflow	7.0B	6.5B	6.6B	4.0B	4.5B
Total Financing Cash Outflow	6.9B	6.9B	7.3B	4.2B	3.3B
Financing Cash Flow	53.4M	-397.0M	-731.0M	-241.0M	1.2B
Net Change In Cash	750.0M	-4.7M	-608.0M	-201.0M	1.6B
Ending Cash Balance	3.4B	2.6B	2.7B	3.3B	3.5B
Capex	148.0M	173.0M	183.0M	264.0M	262.0M